Secondary Therapy, Metastatic Progression, and Cancer-Specific Mortality in Men with Clinically High-Risk Prostate Cancer Treated with Radical Prostatectomy Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Prostatectomy
  • Prostatic Neoplasms

abstract

  • Commonly used definitions for high-risk prostate cancer identify men at increased risk of secondary cancer therapy, metastatic progression, and PCSM following RP. However, a substantial proportion of high-risk patients remain free from additional therapy or metastatic disease many years after surgery. The risk of PCSM within 10 yr of treatment is remarkably low, even for patients at the highest risk of recurrent disease.

publication date

  • May 2008

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC2637146

Digital Object Identifier (DOI)

  • 10.1016/j.eururo.2007.10.008

PubMed ID

  • 17950521

Additional Document Info

start page

  • 950

end page

  • 9

volume

  • 53

number

  • 5